Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis
Archives of Pharmacy and Pharmaceutical Sciences · 2018
DOI: 10.29328/journal.apps.1001008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Pharmacy and Pharmaceutical Sciences, 2018. Verfasst von Heba A Alqurashi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idiopathic arthritis who developed peripheral neuropathy few months after TNF inhibitor withdrawal with clinical worsening of the neurological sequelae while undergoing treatment with abatacept.
Zitieren
APA
Alqurashi, H. A., Al-Salmi, G., Al-Muhaizea, M. A., & Al-Mayouf, S. M. (2018). Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis. Archives of Pharmacy and Pharmaceutical Sciences. https://doi.org/10.29328/journal.apps.1001008
Vancouver
Alqurashi HA, Al-Salmi G, Al-Muhaizea MA, Al-Mayouf SM. Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis. Archives of Pharmacy and Pharmaceutical Sciences. 2018. doi:10.29328/journal.apps.1001008
BibTeX
@article{Alqurashi2018,
author = {Alqurashi, Heba A and Al-Salmi, Ghada and Al-Muhaizea, Mohammad A and Al-Mayouf, Sulaiman M},
title = {Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis},
journal = {Archives of Pharmacy and Pharmaceutical Sciences},
year = {2018},
doi = {10.29328/journal.apps.1001008}
}
EUVIMED